Literature DB >> 18951416

Selenopeptide chemistry.

Markus Muttenthaler1, Paul F Alewood.   

Abstract

This review focuses on the chemical aspects of the 21st proteinogenic amino acid, selenocysteine in peptides and proteins. It describes the physicochemical properties of selenium/sulfur and selenocysteine/cysteine based on comprehensive structural (X-ray, NMR, CD) and biological data, and illustrates why selenocysteine is considered the most conservative substitution of cysteine. The main focus lies on the synthetic methods on selenocysteine incorporation into peptides and proteins, including an overview of the selenocysteine building block syntheses for Boc- and Fmoc-SPPS. Selenocysteine-mediated reactions such as native chemical ligation and dehydroalanine formation are addressed towards peptide conjugation. Selenopeptides have very interesting and distinct properties which lead to a diverse range of applications such as structural, functional and mechanistic probes, robust scaffolds, enzymatic reaction design, peptide conjugations and folding tools. Copyright 2008 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951416     DOI: 10.1002/psc.1075

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  25 in total

1.  Site-specific effects of diselenide bridges on the oxidative folding of a cystine knot peptide, omega-selenoconotoxin GVIA.

Authors:  Konkallu Hanumae Gowd; Viktor Yarotskyy; Keith S Elmslie; Jack J Skalicky; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Biochemistry       Date:  2010-03-30       Impact factor: 3.162

2.  Design of a selenylsulfide-bridged EGFR dimerization arm mimic.

Authors:  Laura E Hanold; Christopher P Watkins; Norman T Ton; Peter Liaw; Aaron M Beedle; Eileen J Kennedy
Journal:  Bioorg Med Chem       Date:  2015-03-20       Impact factor: 3.641

3.  One-pot organocatalytic/multicomponent approach for the preparation of novel enantioenriched non-natural selenium-based peptoids and peptide-peptoid conjugates.

Authors:  Alexander F de la Torre; Akbar Ali; Fábio Z Galetto; Antonio L Braga; José A C Delgado; Márcio W Paixão
Journal:  Mol Divers       Date:  2019-02-18       Impact factor: 2.943

Review 4.  Trends in peptide drug discovery.

Authors:  Markus Muttenthaler; Glenn F King; David J Adams; Paul F Alewood
Journal:  Nat Rev Drug Discov       Date:  2021-02-03       Impact factor: 84.694

5.  Disulfide-Depleted Selenoconopeptides: a Minimalist Strategy to Oxidative Folding of Cysteine-Rich Peptides.

Authors:  Tiffany S Han; Min-Min Zhang; Konkallu Hanumae Gowd; Aleksandra Walewska; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj
Journal:  ACS Med Chem Lett       Date:  2010-05-03       Impact factor: 4.345

Review 6.  Chemoenzymatic Semisynthesis of Proteins.

Authors:  Robert E Thompson; Tom W Muir
Journal:  Chem Rev       Date:  2019-11-27       Impact factor: 60.622

7.  Does dietary copper supplementation enhance or diminish PCB126 toxicity in the rodent liver?

Authors:  Ian K Lai; William D Klaren; Miao Li; Brian Wels; Donald L Simmons; Alicia K Olivier; Wanda M Haschek; Kai Wang; Gabriele Ludewig; Larry W Robertson
Journal:  Chem Res Toxicol       Date:  2013-04-15       Impact factor: 3.739

8.  Expanding chemical diversity of conotoxins: peptoid-peptide chimeras of the sodium channel blocker μ-KIIIA and its selenopeptide analogues.

Authors:  Aleksandra Walewska; Tiffany S Han; Min-Min Zhang; Doju Yoshikami; Grzegorz Bulaj; Krzysztof Rolka
Journal:  Eur J Med Chem       Date:  2013-05-01       Impact factor: 6.514

Review 9.  Using chemical approaches to study selenoproteins-focus on thioredoxin reductases.

Authors:  Robert J Hondal
Journal:  Biochim Biophys Acta       Date:  2009-05-04

10.  Integrated oxidative folding of cysteine/selenocysteine containing peptides: improving chemical synthesis of conotoxins.

Authors:  Aleksandra Walewska; Min-Min Zhang; Jack J Skalicky; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.